Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.

Seyedsadr MS, Weinmann O, Amorim A, Ineichen BV, Egger M, Mirnajafi-Zadeh J, Becher B, Javan M, Schwab ME.

Neurobiol Dis. 2019 Apr;124:189-201. doi: 10.1016/j.nbd.2018.11.018. Epub 2018 Nov 22.

PMID:
30468865
2.

Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.

Ineichen BV, Kapitza S, Bleul C, Good N, Plattner PS, Seyedsadr MS, Kaiser J, Schneider MP, Zörner B, Martin R, Linnebank M, Schwab ME.

Acta Neuropathol. 2017 Sep;134(3):423-440. doi: 10.1007/s00401-017-1745-3. Epub 2017 Jun 23.

3.

Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm.

Pourabdolhossein F, Mozafari S, Morvan-Dubois G, Mirnajafi-Zadeh J, Lopez-Juarez A, Pierre-Simons J, Demeneix BA, Javan M.

PLoS One. 2014 Sep 3;9(9):e106378. doi: 10.1371/journal.pone.0106378. eCollection 2014.

4.

IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.

Psachoulia K, Chamberlain KA, Heo D, Davis SE, Paskus JD, Nanescu SE, Dupree JL, Wynn TA, Huang JK.

Brain. 2016 Dec;139(Pt 12):3121-3136. Epub 2016 Oct 25.

5.

Basic fibroblast growth factor potentiates myelin repair following induction of experimental demyelination in adult mouse optic chiasm and nerves.

Dehghan S, Javan M, Pourabdolhossein F, Mirnajafi-Zadeh J, Baharvand H.

J Mol Neurosci. 2012 Sep;48(1):77-85. doi: 10.1007/s12031-012-9777-6. Epub 2012 May 3.

PMID:
22552714
6.

E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.

Church JS, Milich LM, Lerch JK, Popovich PG, McTigue DM.

Glia. 2017 Jun;65(6):883-899. doi: 10.1002/glia.23132. Epub 2017 Mar 2.

7.

Failure of remyelination in the nonhuman primate optic nerve.

Lachapelle F, Bachelin C, Moissonnier P, Nait-Oumesmar B, Hidalgo A, Fontaine D, Baron-Van Evercooren A.

Brain Pathol. 2005 Jul;15(3):198-207.

PMID:
16196386
8.

Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.

Cruz-Orengo L, Daniels BP, Dorsey D, Basak SA, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, Klein RS.

J Clin Invest. 2014 Jun;124(6):2571-84. doi: 10.1172/JCI73408. Epub 2014 May 8.

9.

Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.

Zhang J, Zhang ZG, Li Y, Lu M, Zhang Y, Elias SB, Chopp M.

Neurobiol Dis. 2016 Apr;88:85-95. doi: 10.1016/j.nbd.2016.01.010. Epub 2016 Jan 12.

PMID:
26805386
10.

Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination.

Seifert T, Bauer J, Weissert R, Fazekas F, Storch MK.

Acta Neuropathol. 2007 Feb;113(2):195-203. Epub 2006 Nov 30.

PMID:
17136549
11.

Apolipoprotein E Mimetic Promotes Functional and Histological Recovery in Lysolecithin-Induced Spinal Cord Demyelination in Mice.

Gu Z, Li F, Zhang YP, Shields LB, Hu X, Zheng Y, Yu P, Zhang Y, Cai J, Vitek MP, Shields CB.

J Neurol Neurophysiol. 2013 Apr;2014(Suppl 12):10.

12.

Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.

Kucharova K, Chang Y, Boor A, Yong VW, Stallcup WB.

J Neuroinflammation. 2011 Nov 13;8:158. doi: 10.1186/1742-2094-8-158.

13.

Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.

Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, Ffrench-Constant C, Franklin RJ, Hoekstra D, Zhao C, Baron W.

Brain. 2013 Jan;136(Pt 1):116-31. doi: 10.1093/brain/aws313.

PMID:
23365094
14.

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.

Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J.

J Neurocytol. 2002 Jul-Aug;31(6-7):523-36.

PMID:
14501221
15.

Myelin regulatory factor drives remyelination in multiple sclerosis.

Duncan GJ, Plemel JR, Assinck P, Manesh SB, Muir FGW, Hirata R, Berson M, Liu J, Wegner M, Emery B, Moore GRW, Tetzlaff W.

Acta Neuropathol. 2017 Sep;134(3):403-422. doi: 10.1007/s00401-017-1741-7. Epub 2017 Jun 19.

PMID:
28631093
16.
17.

Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.

Asghari AA, Azarnia M, Mirnajafi-Zadeh J, Javan M.

J Neurol Sci. 2013 Feb 15;325(1-2):22-8. doi: 10.1016/j.jns.2012.11.008. Epub 2012 Dec 20.

PMID:
23260322
18.

Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.

Kataria H, Alizadeh A, Shahriary GM, Saboktakin Rizi S, Henrie R, Santhosh KT, Thliveris JA, Karimi-Abdolrezaee S.

Glia. 2018 Mar;66(3):538-561. doi: 10.1002/glia.23264. Epub 2017 Nov 17.

PMID:
29148104
19.

The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Tejedor LS, Wostradowski T, Gingele S, Skripuletz T, Gudi V, Stangel M.

J Mol Neurosci. 2017 Apr;61(4):479-488. doi: 10.1007/s12031-017-0888-y. Epub 2017 Jan 26.

PMID:
28124770
20.

Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression.

Alrehaili AA, Lee JY, Bakhuraysah MM, Kim MJ, Aui PM, Magee KA, Petratos S.

Neural Regen Res. 2018 May;13(5):896-907. doi: 10.4103/1673-5374.232488.

Supplemental Content

Support Center